Benzinga | May 26, 2021 07:45AM EDT

CureVac Q1 Operating Loss 115.8M

Operating loss was (euro)115.8 million for the first three months of 2021, representing an increase of (euro)92.6 million, or 339.0%, from operating loss of (euro)23.2 million for the same period in 2020.